These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20380782)

  • 1. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.
    Frank E; Cassano GB; Rucci P; Thompson WK; Kraemer HC; Fagiolini A; Maggi L; Kupfer DJ; Shear MK; Houck PR; Calugi S; Grochocinski VJ; Scocco P; Buttenfield J; Forgione RN
    Psychol Med; 2011 Jan; 41(1):151-62. PubMed ID: 20380782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.
    Rucci P; Frank E; Scocco P; Calugi S; Miniati M; Fagiolini A; Cassano GB
    Depress Anxiety; 2011 Apr; 28(4):303-9. PubMed ID: 21308882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combination.
    Rucci P; Frank E; Calugi S; Miniati M; Benvenuti A; Wallace M; Fagiolini A; Maggi L; Kupfer DJ; Cassano GB
    Depress Anxiety; 2011 Nov; 28(11):955-62. PubMed ID: 21898715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management.
    Reynolds CF; Dew MA; Martire LM; Miller MD; Cyranowski JM; Lenze E; Whyte EM; Mulsant BH; Pollock BG; Karp JF; Gildengers A; Szanto K; Dombrovski AY; Andreescu C; Butters MA; Morse JQ; Houck PR; Bensasi S; Mazumdar S; Stack JA; Frank E
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1134-41. PubMed ID: 20957693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.
    Lespérance F; Frasure-Smith N; Koszycki D; Laliberté MA; van Zyl LT; Baker B; Swenson JR; Ghatavi K; Abramson BL; Dorian P; Guertin MC;
    JAMA; 2007 Jan; 297(4):367-79. PubMed ID: 17244833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity to change and predictive validity of the MOODS-SR questionnaire, last-month version.
    Miniati M; Rucci P; Frank E; Oppo A; Kupfer DJ; Fagiolini A; Cassano GB
    Psychother Psychosom; 2009; 78(2):116-24. PubMed ID: 19218830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early symptom change prediction of remission in depression treatment.
    Katz MM; Meyers AL; Prakash A; Gaynor PJ; Houston JP
    Psychopharmacol Bull; 2009; 42(1):94-107. PubMed ID: 19204654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
    Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
    Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety impairs depression remission in partial responders during extended treatment in late-life.
    Greenlee A; Karp JF; Dew MA; Houck P; Andreescu C; Reynolds CF
    Depress Anxiety; 2010 May; 27(5):451-6. PubMed ID: 20186975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderators of remission with interpersonal counselling or drug treatment in primary care patients with depression: randomised controlled trial.
    Menchetti M; Rucci P; Bortolotti B; Bombi A; Scocco P; Kraemer HC; Berardi D;
    Br J Psychiatry; 2014 Feb; 204(2):144-50. PubMed ID: 24311553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE).
    Frasure-Smith N; Koszycki D; Swenson JR; Baker B; van Zyl LT; Laliberté MA; Abramson BL; Lambert J; Gravel G; Lespérance F
    Psychosom Med; 2006; 68(1):87-93. PubMed ID: 16449416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?
    Gerra ML; Marchesi C; Amat JA; Blier P; Hellerstein DJ; Stewart JW
    J Clin Psychiatry; 2014 Sep; 75(9):e939-44. PubMed ID: 25295437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?
    Dombrovski AY; Cyranowski JM; Mulsant BH; Houck PR; Buysse DJ; Andreescu C; Thase ME; Mallinger AG; Frank E
    Depress Anxiety; 2008; 25(12):1060-6. PubMed ID: 18781665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting remission by 8 weeks: when should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor?
    Cooper-Kazaz R; Rigbi A; Lerer B
    Compr Psychiatry; 2011; 52(1):9-16. PubMed ID: 21220060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results.
    Schramm E; van Calker D; Dykierek P; Lieb K; Kech S; Zobel I; Leonhart R; Berger M
    Am J Psychiatry; 2007 May; 164(5):768-77. PubMed ID: 17475736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.